临床药师服务与全关节置换术预后改善及费用节约相关
这项前瞻性干预序贯队列研究评估骨科临床药师服务对全关节置换术(TJA)并发症率和费用的影响,比较基线期与实施后20个月共1715例手术。实施后术后再入院率(1.3% vs 4.8%,P=.002)降低,静脉血栓栓塞率降至零(0.0% vs 0.6%,P=.13),并发症率1.8% vs 3.4%(P=.760),平均住院日未变(2.8 vs 2.9天),估计年净节约费用73,410美元。
要点
- 药师服务实施后再入院率由4.8%降至1.3%(P=.002)。
- 术后静脉血栓栓塞率降至0.0%(基线0.6%,P=.13)。
- 估计为机构年净节约费用73,410美元。
核心结论
- 为TJA患者整合临床药师服务与机构预后指标有临床意义的改善相关,可能带来显著成本效益。
研究设计与样本
- 前瞻性、干预性、序贯队列研究,经机构审查委员会批准。
- 比较2015年7月至2016年2月基线期与2016年9月至2017年2月实施后期间,设6个月导入期。
- 研究期间共实施1715例TJA手术,并进行出院后RN-administered患者调查和探索性经济评估。
主要发现
- 实施后术后再入院率为1.3% vs 4.8%(P=.002),并发症率为1.8% vs 3.4%(P=.760)。
- 实施后术后VTE率降至0.0% vs 0.6%(P=.13),平均住院日未变(2.8 vs 2.9天)。
- 患者自评出院药物理解改善,对药师互动满意度很高。
关键数值与推荐
- 实施后术后再入院率1.3% vs 4.8%(P=.002)。
- 实施后并发症率1.8% vs 3.4%(P=.760)。
- 实施后VTE率0.0% vs 0.6%(P=.13)。
- 平均住院日2.8 vs 2.9天。
- 估计年净费用节约73,410美元。
临床怎么用
- 可考虑为TJA患者整合临床药师服务以优化药物治疗并降低再入院。
- 药师服务可能改善患者对出院药物的理解及满意度。
- 该服务可能为机构带来成本节约。
局限性
- 研究为序贯队列设计,非随机对照。
- 并发症率差异无统计学意义(P=.760)。
- VTE率差异无统计学意义(P=.13)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Institutions providing total joint arthroplasty (TJA) procedures are subject to substantial outcomes reporting, including those influencing payment for services. Although clinical pharmacists are well-poised to add value, a comprehensive approach to optimizing pharmacotherapy across the care continuum for TJA patients has not been described. METHODS: This prospective, interventional, sequential cohort study was approved by our Institutional Review Board. The objective was to assess the impact of an Orthopedic Clinical Pharmacist service on institutional TJA complication rates and costs. Outcomes were compared for a Baseline period of July 2015 to February 2016 and a Post-implementation period of September 2016 to February 2017, allowing for a 6-month run-in period. Additionally, we pursued a post-discharge, RN-administered patient survey and an exploratory economic assessment. RESULTS: A total of 1715 TJA procedures were performed at the institution during the 20-month study timeframe. Postoperative readmission rate (1.3% vs 4.8%, P = .002) and complication rate (1.8% vs 3.4%, P = .760) were lower in the Post-implementation period. Postoperative VTE rate decreased to zero in the Post-implementation period (0.0% vs 0.6%, P = .13) and average hospital length of stay was unchanged (2.8 vs 2.9 days). Patient self-rated understanding of discharge medications was improved and satisfaction with pharmacist interaction was very high. The service conferred an estimated $73,410 net annual cost savings to the institution. CONCLUSION: Integration of a clinical pharmacist service for TJA patients was associated with clinically meaningful improvements in institutional outcomes, likely conferring substantial cost-benefit.
引用
- Hyland SJ, Kramer BJ, Fada RA, et al. Clinical Pharmacist Service Associated With Improved Outcomes and Cost Savings in Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 32389406. doi:10.1016/j.arth.2020.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。